Neoadjuvant PD-1 blockade plus chemotherapy induces a high pathological complete response rate and anti-tumor immune subsets in clinical stage III gastric cancer

First-line PD-1 blockade plus chemotherapy significantly improves the survival benefits in late-stage gastric cancer (GC) patients. However, the pathological response rate and effects on the immune microenvironment of neoadjuvant PD-1 blockade plus chemotherapy in patients with cTNM-stage III GC rem...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Xiaohuan, Li, Mengyuan, Wu, Xiaolong, Guo, Ting, Zhang, Li, Tang, Lei, Jia, Fangzhou, Hu, Ying, Zhang, Yan, Xing, Xiaofang, Shan, Fei, Gao, Xiangyu, Li, Ziyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578498/
https://www.ncbi.nlm.nih.gov/pubmed/36268179
http://dx.doi.org/10.1080/2162402X.2022.2135819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578498/
https://www.ncbi.nlm.nih.gov/pubmed/36268179
http://dx.doi.org/10.1080/2162402X.2022.2135819

Ejemplares similares